Huntington National Bank
ABCL icon

Huntington National Bank’s AbCellera Biologics ABCL Stock Holding History

Huntington National Bank’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-803
Closed -$5.19K – 3830
2023
Q2 		$5.19K Buy
+803
New +$5.48K ﹤0.01% 1791

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Huntington National Bank's ABCL Position: Q3 2023 in Review

Huntington National Bank sold out of AbCellera Biologics (ABCL) in Q3 2023, closing a stake of 803 shares — an estimated $5.19K sold.

Huntington National Bank first reported a position in ABCL in Q2 2023 and held it in 1 quarter. The position peaked at $5.19K in Q2 2023. 138 funds tracked by Wall St. Rank hold ABCL as of Q3 2023.

  • Huntington National Bank reported no remaining AbCellera Biologics position as of Q3 2023 after selling out during the quarter.
  • Huntington National Bank sold 803 AbCellera Biologics shares in Q3 2023, an estimated $5.19K.
  • Huntington National Bank first reported a position in AbCellera Biologics in Q2 2023 and held it in 1 quarter.
  • Huntington National Bank's AbCellera Biologics position peaked at $5.19K in Q2 2023.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2023.

Based on Huntington National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.